Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: FJB who wrote (3411)	12/5/2013 7:44:06 PM
From: scaram(o)uche	2 Recommendations Recommended By rkrw Savant Read Replies (1) \| Respond to of 3576

I'm not going to suggest to ANYONE that they should buy GERN. Period! And Dr. T. is only talking upside, thus far. But your fundamental premise is flawed.... Incyte's jakafi is widely considered as palliative only, and they've not fully penetrated the market. And yet it's selling at an annualized $240 million per year ($60 million last quarter, MF only)..... finance.yahoo.com It's a small market, not a miniscule one. Monday will be extremely volatile, one way or the other. Sucks that someone broke the embargo. Note that I have a modest position.